Grazoprevir Market - Explore Top Factors that Will Boost the Global Market in Future

The 𝐆𝐫𝐚𝐳𝐨𝐩𝐫𝐞𝐯𝐢𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 has evolved since it was first approved for the treatment of chronic hepatitis C virus (HCV) infection in 2016. Initially, grazoprevir was launched as a combination therapy with elbasvir under the brand name Zepatier, and it was positioned as an alternative treatment option for HCV genotype 1 and 4 infections.

However, since the introduction of Zepatier, there have been several newer and more effective treatments for HCV, such as the combination of sofosbuvir and Velpatasvir. These newer treatments have gradually replaced Zepatier and grazoprevir in the HCV treatment landscape, resulting in a decline in the market for grazoprevir.

As a result, the manufacturer of grazoprevir, Merck & Co., Inc., announced in 2018 that it would be discontinuing the production and distribution of Zepatier by the end of 2020 in most markets. However, it should be noted that Zepatier is still available in some countries, and it may still be used in certain circumstances, depending on the patient's specific HCV genotype and treatment history.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.alliedmarketresearch.com/request-toc-and-sample/12844

𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19.

Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the grazoprevir market.

Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/33b9a2a7105e18c839f79455779374af

The World Health Organization (WHO) on January 30, 2020, declared COVID-19 outbreak a public health emergency of international concern. Grazopervir API and tablet manufacturing and distributing companies have been affected by COVID-19 to a limited extent, owing to shut down in various COVID-19 affected countries and rise in number of healthcare workers falling ill in the wake of the COVID-19 pandemic, leading to supply shortage.
Top Impacting Factors

𝐑𝐢𝐬𝐞 𝐢𝐧 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐇𝐞𝐩𝐚𝐭𝐢𝐭𝐢𝐬 𝐂 𝐜𝐚𝐬𝐞𝐬 𝐢𝐬 𝐥𝐢𝐤𝐞𝐥𝐲 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐟𝐚𝐜𝐭𝐨𝐫 𝐨𝐟 𝐠𝐫𝐚𝐳𝐨𝐩𝐫𝐞𝐯𝐢𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐲𝐞𝐚𝐫𝐬. However, the restraints to the market are self-imitating nature of the disease in a sizable number of patients, challenge of herbal treatment offered at negligible prices especially in developing regions, price war between companies, rising urbanization, and better sanitation.
Several new drugs have been launched in recent times, due to the high prevalence of hepatitis C across the world, which can restrain the

The global Grazoprevir Drug Market is expected to witness significant growth during the forecast period. Key players such as Merck & Co. has taken initiative for the treatment of hepatitis C infection in Africa by formulation of grazoprevir. Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stages of hepatitis C can also lead to liver damage, thereby creating severe health risks. The severity of hepatitis C has created a huge emphasis on the R&D of drugs associated with the treatment of this disease.

𝐓𝐨𝐩 𝐈𝐦𝐩𝐚𝐜𝐭𝐢𝐧𝐠 𝐅𝐚𝐜𝐭𝐨𝐫𝐬:

• Rise in prevalence of Hepatitis C cases is likely the key driving factor of grazoprevir market in upcoming years.
• However, the restraints to the market are self-imitating nature of the disease in a sizable number of patients, challenge of herbal treatment offered at negligible prices especially in developing regions, price war between companies, rising urbanization, and better sanitation.
• Several new drugs have been launched in recent times, due to the high prevalence of hepatitis C across the world, which can restrain the grazoprevir market growth.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐚𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/12844

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:

• This report presents the detailed analytical depiction of the grazoprevir market along with current trends, opportunities, and future estimates for the market.
• The report presents information related to the key drivers, restraints, and opportunities in the grazoprevir market.
• The current market is analyzed from 2020 to 2028 to emphasize the grazoprevir market.
• Porter's five forces analysis illustrate the potency of buyers and suppliers in market.
• The report provides a detailed analysis of the grazoprevir market based on market competition and how it will take shape in upcoming years.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Electroceuticals Medicine Market>> https://www.alliedmarketresearch.com/electroceuticals-medicine-market-A06258

Atherectomy Device Market>> https://www.alliedmarketresearch.com/atherectomy-device-market-A06259

𝐀𝐕𝐄𝐍𝐔𝐄- 𝐀 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐁𝐚𝐬𝐞𝐝 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Contact Us:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.